News & Articles

Driven by the gap in COVID-19 testing, the collaboration aims to create a fully disposable, rapid and handheld test for consumers

COVID-DPR is a virtual collection of high-resolution microscopic COVID-related human tissue images hosted at the National Institutes of Health

Dr. Sylvia Boj discusses the advantages of organoids and how these 3D tissue cultures have enormous potential to revolutionize how we treat patients and predict therapeutic response

Register for this webinar to learn more about how live-cell monitoring can support optimization of advanced cellular models

Platform to complement Rentschler’s cell line development offering for difficult-to-express proteins

A qualitative test for the detection of nucleic acid from SARS-CoV-2

Onxeo to present new preclinical data at AACR 2020 illustrating the ability of AsiDNA™

Study suggests that type I IFN deficiency in the blood could help define a high-risk population

The COVID-19 vaccine trial is part of a global development program that will uncover the safety and immunogenicity of four mRNA vaccine candidates.

Test deployed on Quanterix' Simoa platform promises 1,000-fold sensitivity improvement

The latest imaging system promises high-resolution, sensitivity and reliability in a compact system

Learn how unique automation of some of the most routine processes in a workflow can transform emerging biotechnology companies

Science industry comes together online to share knowledge and provide technology solutions for cancer and immunology research

From AI to artificial lifeforms, we spotlight the latest research and automation solutions innovating life sciences and drug discovery

Assay will help guide treatment decisions in cases of non-small cell lung cancer

The company says it continues to optimize its coronavirus test amid questions about its accuracy

Instrument was voted for by scientists around the globe as the Best New Life Sciences Product, at the 2020 Scientists’ Choice Awards

Collaboration with WuXi Diagnostics and Mayo Clinic on serology test will complement Thermo Fisher's widely adopted TaqPath COVID-19 molecular diagnostic test